TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer

NCT00057720 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Neoplasms

Interventions

DRUG: TLK286 HCl for injection
DRUG: topotecan hydrochloride for injection
DRUG: doxorubicin HCl liposome injection

Sponsor

Telik